Published January 15, 2013 | Version v1
Journal article

Precise control of the drug kinetics by means of non-invasive magnetic drug delivery system

  • 1. Division of Sustainable Energy and Environmental Engineering, Graduate School of Engineering, Osaka University, A1 Bldg., 2-8 Yamadaoka, Suita, Osaka 565-0871 (Japan)

Description

Highlights: ► We examined the kinetics of ferromagnetic drugs by simulation. ► We tried to accumulate the magnetic drug in the target part by rotating a magnet. ► Ferromagnetic drugs were accumulated in the target part along the rotating axis. ► Ferromagnetic drugs could be swept downstream in the off-axis part. -- Abstract: In order to solve the problems of the side effects and medical lowering, has been advanced a study on the drug delivery system (DDS) to accumulate the drugs locally in the body with minimum dosage. The DDS is a system that controls the drug kinetics in the body precisely and accumulates the drug locally at the target part, keeping the drugs at high density. Among the DDS, the magnetic drug delivery system (MDDS) is the one that we studied. This is a technique to accumulate drugs by using the magnetic force as the physical driving force. Our previous researches showed the possibility of the technique of MDDS to accumulate the drugs with higher accumulation rate and locality than the traditional methods. It is necessary to apply a strong external magnetic field and a high magnetic gradient to accumulate the ferromagnetic drugs at a deep diseased part non-invasively. However, by applying a static magnetic field from one direction, the drug accumulates only at the surface of the body locates near the magnet. In this study, we tried to change the magnetic field applied by a superconducting bulk magnet with time, in order to make a constant and strong magnetic field applied in the center of the body and to accumulate the ferromagnetic drugs at the deep target part in the body. First of all, the effect of the surface treatment of the ferromagnetic drugs to prevent its absorption in the normal tissue was examined. Then, to increase the accumulation rate of the ferromagnetic drugs at the target part, the distribution of magnetic field was changed, and the optimum spatial and temporal conditions of magnetic field were examined

Availability note (English)

Available from http://dx.doi.org/10.1016/j.physc.2012.03.070

Additional details

Identifiers

DOI
10.1016/j.physc.2012.03.070;
PII
S0921-4534(12)00177-3;

Publishing Information

Journal Title
Physica. C, Superconductivity
Journal Volume
484
Journal Page Range
p. 120-124
ISSN
0921-4534
CODEN
PHYCE6

Conference

Title
24. international symposium on superconductivity
Acronym
ISS2011
Dates
24-26 Oct 2011
Place
Tokyo (Japan)

INIS

Country of Publication
Netherlands
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
45057314
Subject category
S75: CONDENSED MATTER PHYSICS, SUPERCONDUCTIVITY AND SUPERFLUIDITY;
Resource subtype / Literary indicator
Conference
Descriptors DEI
ABSORPTION; BUILDUP; CONTROL; DELIVERY; DENSITY; DRUGS; FERROMAGNETIC MATERIALS; KINETICS; MAGNETIC FIELDS; MAGNETS; SIDE EFFECTS; SIMULATION; SURFACE TREATMENTS
Descriptors DEC
EQUIPMENT; MAGNETIC MATERIALS; MATERIALS; PHYSICAL PROPERTIES; SORPTION

Optional Information

Copyright
Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.